Stereo Acuity

Binocular disparity supplies the visual system with a horizontal comparison between corresponding features in the two eye images. The clinically relevant limit is how small a disparity a person can detect reliably. Testing therefore converts the comparison process into a threshold, allowing clinicians to describe depth discrimination more precisely than by simply recording whether three-dimensional vision is present.

Seconds of arc express the angular size of the separation between corresponding visual features. In stereo acuity testing, the reported value represents the smallest controlled disparity that the patient can detect. This measurement provides a standardized way to compare binocular visual performance across examinations and to identify changes during clinical follow-up.

Reduced performance may signal that binocular vision has not developed normally or that the two eyes are not contributing effectively to a shared visual representation. The overview identifies strabismus, amblyopia, and impaired visual development as relevant clinical conditions. Consequently, an abnormal result can provide evidence supporting further assessment of binocular function rather than serving as an isolated diagnosis.

A clinical test presents visual targets containing controlled binocular disparities and determines the smallest separation the patient can detect. The result is recorded in seconds of arc, creating a quantitative measure rather than a purely descriptive observation. This procedure focuses the examination on fine depth discrimination and permits results to be compared across evaluations.

Clinicians use the assessment to evaluate binocular vision when investigating conditions such as strabismus, amblyopia, or impaired visual development. It can contribute to diagnosis by revealing reduced depth-discrimination performance. Because the test produces a measurable threshold, it also supplies information that complements the broader clinical evaluation of how the two eyes function together.

Repeated measurements can show whether binocular visual performance changes during treatment or follow-up. The threshold provides an objective indicator that can be compared over time, while the clinical context determines its significance. Stereo acuity assessment therefore helps monitor treatment and evaluate functional visual outcomes, rather than limiting assessment to structural findings or a single diagnostic visit.